What is the future of the blood plasma derivatives market?
The blood plasma derivatives market is expected to reach a CAGR of 4.3% during the forecast period (2022-2029), driven by factors such as the increasing prevalence of hemophilia and the growing awareness of the use and availability of plasma derivatives.
Who are the major players in the blood plasma derivatives market?
The major players in the blood plasma derivatives market include Grifols, S.A., SK Plasma Co., Ltd., Baxter International Inc., CSL Limited, and Shire Plc. These players are adopting various growth strategies such as product launches, acquisitions, and collaborations to expand their market share.